Deerfield Healthcare Innovations Fund, L.P.

USReporting entityDirector

USReporting entityDirector

Transactions

Issuers

Buys / Sells

6/9

Last tx

15 Dec 2022

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
Nuvalent, Inc.	8,772,840	reported	02 Aug 2021	tx 14+24,218,878−127,119,880
GRAYBUG VISION, INC.	1,713,873	reported	29 Sept 2020	tx 11+5,281,713−33,494,525
Oncorus, Inc.	1,395,768	reported	15 Dec 2022	tx 22+2,848,970−22,363,067

Recent transactions

Date	Type	Issuer	Qty	Price	Signals
13 Dec 2022	SALE	Oncorus, Inc.	230	0.41 USD
14 Dec 2022	SALE	Oncorus, Inc.	3,828	0.38 USD
14 Dec 2022	SALE	Oncorus, Inc.	3,829	0.38 USD
14 Dec 2022	SALE	Oncorus, Inc.	943	0.38 USD
13 Dec 2022	SALE	Oncorus, Inc.	933	0.41 USD
15 Dec 2022	SALE	Oncorus, Inc.	1,375	0.39 USD
15 Dec 2022	SALE	Oncorus, Inc.	339	0.39 USD
13 Dec 2022	SALE	Oncorus, Inc.	934	0.41 USD
15 Dec 2022	SALE	Oncorus, Inc.	1,375	0.39 USD
02 Aug 2021	CONVERSION	Nuvalent, Inc.	897,671	—
02 Aug 2021	CONVERSION	Nuvalent, Inc.	897,671	—
02 Aug 2021	CONVERSION	Nuvalent, Inc.	8,494,140	—
02 Aug 2021	CONVERSION	Nuvalent, Inc.	8,494,140	—
02 Aug 2021	PURCHASE	Nuvalent, Inc.	300,000	17.00 USD	deriv
02 Aug 2021	PURCHASE	Nuvalent, Inc.	300,000	17.00 USD	deriv
02 Aug 2021	CONVERSION	Nuvalent, Inc.	2,417,628	—	deriv
02 Aug 2021	CONVERSION	Nuvalent, Inc.	2,417,628	—	deriv
02 Aug 2021	CONVERSION	Nuvalent, Inc.	4,831,384	—	deriv
02 Aug 2021	CONVERSION	Nuvalent, Inc.	13,011,988	—	deriv
02 Aug 2021	CONVERSION	Nuvalent, Inc.	13,011,988	—	deriv
02 Aug 2021	CONVERSION	Nuvalent, Inc.	45,716,568	—	deriv
02 Aug 2021	CONVERSION	Nuvalent, Inc.	45,716,568	—	deriv
02 Aug 2021	CONVERSION	Nuvalent, Inc.	4,831,384	—	deriv
06 Oct 2020	CONVERSION	Oncorus, Inc.	620,480	—
06 Oct 2020	CONVERSION	Oncorus, Inc.	620,480	—

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
Nuvalent, Inc.	8,772,840	reported	02 Aug 2021	tx 14+24,218,878−127,119,880
GRAYBUG VISION, INC.	1,713,873	reported	29 Sept 2020	tx 11+5,281,713−33,494,525
Oncorus, Inc.	1,395,768	reported	15 Dec 2022	tx 22+2,848,970−22,363,067

Recent transactions

Date	Type	Issuer	Qty	Price	Signals
13 Dec 2022	SALE	Oncorus, Inc.	230	0.41 USD
14 Dec 2022	SALE	Oncorus, Inc.	3,828	0.38 USD
14 Dec 2022	SALE	Oncorus, Inc.	3,829	0.38 USD
14 Dec 2022	SALE	Oncorus, Inc.	943	0.38 USD
13 Dec 2022	SALE	Oncorus, Inc.	933	0.41 USD
15 Dec 2022	SALE	Oncorus, Inc.	1,375	0.39 USD
15 Dec 2022	SALE	Oncorus, Inc.	339	0.39 USD
13 Dec 2022	SALE	Oncorus, Inc.	934	0.41 USD
15 Dec 2022	SALE	Oncorus, Inc.	1,375	0.39 USD
02 Aug 2021	CONVERSION	Nuvalent, Inc.	897,671	—
02 Aug 2021	CONVERSION	Nuvalent, Inc.	897,671	—
02 Aug 2021	CONVERSION	Nuvalent, Inc.	8,494,140	—
02 Aug 2021	CONVERSION	Nuvalent, Inc.	8,494,140	—
02 Aug 2021	PURCHASE	Nuvalent, Inc.	300,000	17.00 USD	deriv
02 Aug 2021	PURCHASE	Nuvalent, Inc.	300,000	17.00 USD	deriv
02 Aug 2021	CONVERSION	Nuvalent, Inc.	2,417,628	—	deriv
02 Aug 2021	CONVERSION	Nuvalent, Inc.	2,417,628	—	deriv
02 Aug 2021	CONVERSION	Nuvalent, Inc.	4,831,384	—	deriv
02 Aug 2021	CONVERSION	Nuvalent, Inc.	13,011,988	—	deriv
02 Aug 2021	CONVERSION	Nuvalent, Inc.	13,011,988	—	deriv
02 Aug 2021	CONVERSION	Nuvalent, Inc.	45,716,568	—	deriv
02 Aug 2021	CONVERSION	Nuvalent, Inc.	45,716,568	—	deriv
02 Aug 2021	CONVERSION	Nuvalent, Inc.	4,831,384	—	deriv
06 Oct 2020	CONVERSION	Oncorus, Inc.	620,480	—
06 Oct 2020	CONVERSION	Oncorus, Inc.	620,480	—